Chemoinformaics analysis of 16-O-acetylisoiridogermanal
| Molecular Weight | 516.763 | nRot | 14 |
| Heavy Atom Molecular Weight | 464.347 | nRig | 12 |
| Exact Molecular Weight | 516.381 | nRing | 1 |
| Solubility: LogS | -4.49 | nHRing | 0 |
| Solubility: LogP | 5.932 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 92.1232 |
| nHD | 2 | BPOL | 55.6388 |
| QED | 0.084 |
| Synth | 4.857 |
| Natural Product Likeliness | 3.083 |
| NR-PPAR-gamma | 0.102 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.991 |
| Pgp-sub | 0.986 |
| HIA | 0.343 |
| CACO-2 | -4.8 |
| MDCK | 0.000029 |
| BBB | 0.289 |
| PPB | 0.97145 |
| VDSS | 1.2 |
| FU | 0.0438695 |
| CYP1A2-inh | 0.092 |
| CYP1A2-sub | 0.091 |
| CYP2c19-inh | 0.232 |
| CYP2c19-sub | 0.773 |
| CYP2c9-inh | 0.401 |
| CYP2c9-sub | 0.207 |
| CYP2d6-inh | 0.683 |
| CYP2d6-sub | 0.018 |
| CYP3a4-inh | 0.85 |
| CYP3a4-sub | 0.421 |
| CL | 5.075 |
| T12 | 0.123 |
| hERG | 0.024 |
| Ames | 0.006 |
| ROA | 0.004 |
| SkinSen | 0.919 |
| Carcinogencity | 0.048 |
| EI | 0.045 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.823 |
| Antiviral | Yes |
| Prediction | 0.804754 |